Vsc Scottsdale | |
5533 E Bell Rd Ste 109, Scottsdale, AZ 85254-1256 | |
(602) 788-4200 | |
Not Available |
Full Name | Vsc Scottsdale |
---|---|
Type | Facility |
Speciality | Physical Medicine & Rehabilitation |
Location | 5533 E Bell Rd Ste 109, Scottsdale, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033652813 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | (* (Not Available)) | Secondary |
208100000X | Physical Medicine & Rehabilitation | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Vsc Scottsdale 5533 E Bell Rd Ste 109, Scottsdale, AZ 85254-1256 Ph: (602) 788-4200 | Vsc Scottsdale 5533 E Bell Rd Ste 109, Scottsdale, AZ 85254-1256 Ph: (602) 788-4200 |
News Archive
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.
The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation (vasculitis).
Food safety lawyer and Salmonella expert Fred Pritzker said the fast-growing tuna sushi Salmonella outbreak now under federal investigation has undoubtedly sickened thousands of consumers - not just the 93 people whose illnesses have been confirmed in lab tests. Pritzker said the actual number of outbreak victims is likely to be more than 2,700 based on a multiplier of 30.3 unreported or unconfirmed illnesses for every stool-confirmed infection counted by CDC.
Biotechnology firm Viral Genetics, Inc. has been issued a patent for novel cancer therapies. The patent protects cancer drugs that have been tested in pre-clinical research studies in mice. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. Additional patents directed at generic classes of the drugs are still pending.
› Verified 5 days ago